학력

• 연세대학교 의학과 박사 수료

• 2020.02

  인하대학교 의학과 석사

• 2010.02

  인하대학교 의학과 학사

주요경력

• 2025.03 ~ 현재

  인하대병원 호흡기내과 부교수

• 2024.11 ~ 현재

  인하대병원 호흡기내과 과장

• 2020.03 ~ 2025.02

  인하대병원 호흡기내과 조교수

• 2019.03 ~ 2020.02

  인하대학교병원 호흡기내과 임상강사

• 2018.05 ~ 2019.02

  삼성서울병원 호흡기내과 임상강사

• 2015.03 ~ 2018.04

  육군 군의관

• 2011.03 ~ 2015.02

  인하대학교병원 내과 전공의

• 2010.03 ~ 2011.02

  인하대학교병원 인턴

학회활동

• -

  Member of the International Association for the Study of Lung Cancer (IASLC)

• -

  Active member of the American Association for Cancer Research (AACR)

• -

  Member of the International Society of Liquid Biopsy (ISLB)

• -

  대한폐암학회 정회원

• -

  대한암학회 정회원

• -

  한국엑소좀학회 정회원

• -

  Associate Editor, Journal of Translational Medicine

• -

  PLoS ONE 학술편집인

• -

  Discover Oncology 학술편집인

• -

  Scientific Reports 학술편집인

• -

  BMC Pulmonary Medicine 학술편집인

수상경력

• 2022.04

  대한폐암학회 표적치료연구회 연구비 수혜

• 2022.03

  한국연구재단 우수신진연구 연구비 수혜

• 2021.06

  대한폐암학회 젊은연구자상

• 2019.12

  일본폐암학회 Travel Grant Award

• 2019.06

  한국연구재단 기본연구 연구비 수혜

주요 논문 및 저서

• 2026

  Lim JH, Ryu WK, Ryu J-S: Immunotherapy in uncommon EGFR-mutant NSCLC: Revisiting a therapeutic gray zone. Lung Cancer 2026.

• 2026

  Lim JH, Adjei AA: The Perils of AI-Generated Peer Review. Journal of Thoracic Oncology 2026, 21(1):11-13.

• 2025

  Cho E, Choi W, Lim JH, Son JW, Jang SH, Lee SH, Choi JG, Oh I-J, Jang T-W, Yoon SH: Temporal changes in tongue color during immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer: a prospective observational study using digital tongue diagnosis. Oncology Reviews 2025, 19:1697252.

• 2025

  Lim JH, Lee HY, Kim H-C: Trends in the Characteristics of Patients with Lung Cancer in Incheon, Republic of Korea: A Population-Based Study from the Incheon Cancer Registry. The Korean Journal of Medicine 2025, 100(6):299-308.

• 2025

  Ryu WK*, Lim JH*, Ryu JS: Priming for Cure: How Perioperative Immunotherapy Is Redrawing Surgical Boundaries. J Thorac Oncol 2025, 20(11):1561-1564.

• 2025

  Jeong E*, Choi JH*, Lee M*, Lim JH*, Jung S, Woo Y, Kim JY, Ok J, Kim L, Jeong WJ et al: Aptamer-Engineered Ellipsometry for Clinical Detection of BALF-Derived Exosomes: Multi-Level Engineering for Prognostic Evaluation of Immunotherapy Responses. Adv Sci (Weinh) 2025:e15247.

• 2025

  Choi JH*, Cho HM*, Lim JH*, Choi W, Shin D, Son CY, Park HS, Hong S, Kim L, Doh I et al: Ultrasensitive Detection of PD-L1-Expressing Extracellular Vesicles via Reflection-Mediated Ellipsometry: From Nanoscale Optical Modeling to Immunotherapy Response Prediction. Small 2025:e07372.

• 2025

  Ryu WK*, Ganbaatar M*, Park N, Lee HY, Kim HC, Ryu JS, Lim JH: Prognostic Impact of Organ-Specific Metastasis in Non-Small-Cell Lung Cancer. Cancer Res Treat 2025.

• 2025

  Kim MJ, Kwak HS, Koh EN, Park CK, Kim YC, Oh IJ, Kim SJ, Lim JH, Ryu JS, Choi CM: Real-World Outcomes of Brigatinib Compared to Alectinib as a Second-Line Therapy After Crizotinib in Advanced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients. Thorac Cancer 2025, 16(19):e70175.

• 2025

  Kim J-y*, Park HS*, Kang H*, Son CY, Kim HK, Choi JH, Kim L, chan Choi S, Kim Y, Hong S, Kim DH, Lim JH, Bu J#, Jeong W-J#: In silico fragment-based peptide design targeting undruggable proteins for enhanced detection of circulating tumor cells. Chemical Engineering Journal 2025:167447.

• 2025

  Lee J*, Shin D*, Son CY*, Kang H*, Choi JH, Park HS, Bang S, Kim L, Lee TH, Eun HS, Poellmann MJ, Jeong W-J#, Kim DH#, Lim JH#, Hong S#, Bu J#: Avidity‐Based Capture of PD‐L1‐Expressing Exosomes via Dendrimer–Peptide Conjugates: A Nanoengineered Platform for Enhanced Prediction of Immunotherapy Response. Advanced Science 2025:e09270.

• 2025

  Barlesi F, Yao W, Duruisseaux M, Doucet L, Martínez AA, Gregorc V, Juan-Vidal O, Lu S, De Bondt C, de Marinis F, Linardou H, Kim YC, Jotte R, Felip E, Lo Russo G, Reck M, Michenzie MF, Yang W, Meade JN, Korytowsky B, Mok TSK; KRYSTAL-12 Investigators: Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial. The Lancet 2025, 406(10503):615-626.

• 2025

  Chalmers JD, Burgel P-R, Daley CL, De Soyza A, Haworth CS, Mauger D, Loebinger MR, McShane PJ, Ringshausen FC, Blasi F, Shteinberg M, Mange K, Teper A, Fernandez C, Zambrano M, Fan C, Zhang X, Metersky ML; ASPEN Investigators: Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis. New England Journal of Medicine 2025, 392(16):1569-1581.

• 2025

  Lim JU, Ryu WK, Park N, Choi J, Lee E, Lee S-Y, Lim JH: Current and future perspectives in extensive-stage small-cell lung cancer. Therapeutic Advances in Medical Oncology 2025, 17:17588359251326705.

• 2025

  Yeo CD, Park DW, Yoon SH, Kim EY, Lee JE, Lee SY, Choi CM, Oh IJ, Kim DJ, Ryu JS, Lee JC, Kim YC, Jang TW, Lee KY, Jang SH, Kim SJ; Korean EGFR Registry Investigators: Study Protocol of the Korean EGFR Registry: A Multicenter Prospective and Retrospective Cohort Study in Nonsmall Cell Lung Cancer Patients With EGFR Mutation. The Clinical Respiratory Journal 2025, 19(1):e70043.

• 2024

  Lim JH*, Shin H-T*, Park S, Ryu WK, Kim L, Lee K-H, Ko SM, Lee SJ, Kim JS, Ryu J-S: Bronchial washing fluid sequencing is useful in the diagnosis of lung cancer with necrotic tumor. Translational Oncology 2024, 50:102134.

• 2024

  Park JH, Lim JH, Kim S, Kim CH, Choi JS, Lim JH, Kim L, Chang JW, Park D, Lee MW: Deep learning‐based analysis of EGFR mutation prevalence in lung adenocarcinoma H&E whole slide images. The Journal of Pathology: Clinical Research 2024, 10(6):e70004.

• 2024

  Park J, Kim S, Lim JH, Kim C-H, You S, Choi J-S, Lim JH, Chang JW, Park D, Lee MW: Development of a multi-modal learning-based lymph node metastasis prediction model for lung cancer. Clinical Imaging 2024, 114:110254.

• 2024

  Oh SJ, Lim JH, Kim L, Kim YS: Diffuse pulmonary meningotheliomatosis: A case report. Respiratory Medicine Case Reports 2024, 52:102105.

• 2024

  Seo D, Lim JH: Targeted Therapies for EGFR Exon 20 Insertion Mutation in Non-Small-Cell Lung Cancer. International Journal of Molecular Sciences 2024, 25(11):5917.

• 2024

  Kim HH, Lee JC, Oh I-J, Kim EY, Yoon SH, Lee SY, Lee MK, Lee JE, Park CK, Lee KY, Lee SY, Kim SJ, Lim JH, Choi C-M: Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer. Cancers 2024, 16(3):528.

• 2024

  Cha HK, Ryu WK, Lee H-Y, Kim H-J, Ryu J-S#, Lim JH#: Spine Metastasis Is Associated with the Development of Brain Metastasis in Non-Small-Cell Lung Cancer Patients. Medicina 2024, 60(1):152.

• 2024

  Kim S, Lim JH, Kim C-H, Roh J, You S, Choi J-S, Lim JH, Kim L, Chang JW, Park D: Deep learning–radiomics integrated noninvasive detection of epidermal growth factor receptor mutations in non-small cell lung cancer patients. Scientific Reports 2024, 14(1):922.

• 2023

  Ryu WK*, Cha HK*, Kim W, Lee HY, Kim H-J, Ryu J-S#, Lim JH#: Effect of whole-brain radiotherapy with platinum-based chemotherapy in non-small cell lung cancer patients with multiple metastases including brain metastases. Scientific Reports 2023, 13(1):13173.

• 2023

  Lim JH, Lee S, Ryu J-S: Prediction of Treatment Response to Chemoimmunotherapy: Concerted Effort Needed. Journal of Thoracic Oncology 2023, 18(6):682-685.

• 2022

  Ryu WK*, Oh S*, Lim JH, Lee SJ, Shin H-T#, Ryu J-S#: Monitoring Circulating Tumor DNA in Untreated Non-Small-Cell Lung Cancer Patients. International journal of molecular sciences 2022, 23(17):9527.

• 2022

  Lee JH, Kim EY, Park C-K, Lee SY, Yoon SH, Lee JE, Lee SH, Kim SJ, Lee SY, Lim JH: Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation-Positive Non-Small Cell Lung Cancer. Cancer Research and Treatment 2022.

• 2022

  Im JH, Nahm CH, Je YS, Lee J-S, Baek JH, Kwon HY, Chung M-H, Jang J-H, Kim JS, Lim JH, Park MH: The effect of Epstein–Barr virus viremia on the progression to severe COVID-19. Medicine 2022, 101(18):e29027-e29027.

• 2022

  Lee CY*, Shin SH*, Choi HS, Im Y, Kim B-G, Song JY, Lee D, Park HY#, Lim JH#: Association Between Vitamin D Level and Respiratory Symptoms in Patients with Stable Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:579.

• 2021

  Ryu WK*, Kim JS*, Park MH, Lee M, Kim HJ, Ryu JS#, Lim JH#: Heterogeneous radiological response to chemotherapy is associated with poor prognosis in advanced non‐small‐cell lung cancer. Thoracic Cancer 2021.

• 2021

  Lim JH*, Oh S*, Kim L, Suh YJ, Ha Y-J, Kim JS, Kim H-J, Park MH, Kim YS, Cho Y, Kwak SM, Lee HL, Kim Y-S#, Ryu J-S#: Low-level expression of necroptosis factors indicates a poor prognosis of the squamous cell carcinoma subtype of non-small-cell lung cancer. Translational Lung Cancer Research 2021, 10(3):1221-1230.

• 2021

  Moon SM*, Lim JH*, Hong YS, Shin K-C, Lee CY, Kim DJ, Lee SH, Jung KS, Lee C-H, Yoo KH, Lee H#, Park HY#: Clinical impact of forced vital capacity on exercise performance in patients with chronic obstructive pulmonary disease. Journal of Thoracic Disease 2021, 13(2):837.

• 2021

  Ryu W*, Lee MK*, Park MH*, Hyun IY, Lee M, No EJ, Yong SJ, Kim JS, Lim JH#, Ryu JS#: Abdominal lymph node metastasis by lymphatic spread through the thoracic duct in patients with non‐small‐cell lung cancer. Thoracic Cancer 2021.

• 2021

  Lee YS*, Lim JH*, Ryu W, Park MH, Kim L, Kim K, Kim WY, Nam H-S: The clinical impact of three validated PD-L1 immunohistochemistry assays as a prognostic factor in small cell lung cancer. Translational Lung Cancer Research 2021, 10(6):2539-2550.

• 2021

  Ryu WK, Moon Y, Park MH, Lim JH, Kim YS, Lee K-H, Kwak SM, Kim C, Nam H-S: A preliminary study on the prognostic impact of neutrophil to lymphocyte ratio of the bronchoalveolar lavage fluid in patients with lung cancer. Diagnostics 2021, 11(12):2201.

• 2020

  Lim JH*, Kim MJ*, Jeon SH*, Park MH, Kim WY, Lee M, Kim JH, Kim JS, Kim YS, Kim L, Lee KH, Kwak SM, Shin H, Nam HS: the optimal sequence of bronchial brushing and washing for diagnosing peripheral lung cancer using non-guided flexible bronchoscopy. Scientific Reports 2020, 10(1):1-7.

• 2020

  Kim M, Lim JH, Park M, Cha HK, Kim L, Nam HS: A Rare Case of Fatal Endobronchial Mucormycosis Masquerading as Endobronchial Tuberculosis. Medicina 2020, 56(2):64.

• 2020

  Lim JH, Choi JY, Im Y, Yoo H, Jhun BW, Jeong BH, Park HY, Lee K, Kim H, Kwon OJ, Han J, Ahn MJ, Kim J, Um SW: Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in patients with malignant pleural mesothelioma. PloS one 2020, 15(2):e0229299.

• 2020

  Oh S*, Lim JH*, Park N, Choi S, Ryu JS: Dual Inhibition of EGFR and BRAF Can Be Harmful in Patients Harboring an EGFR-Activating Mutation. Journal of Thoracic Oncology 2020, 15(3):e32-e34.

• 2020

  Lim JH*, Kang D*, Hong YS, Kim H, Ryu S, Chang Y, Park HY#, Cho J#: Association between reproductive lifespan and lung function among postmenopausal women. Journal of Thoracic Disease 2020, 12(8):4243-4252.

• 2020

  Shin SH*, Kang N*, Cho J, Choi Y, Cho HK, Choi HS, Kim H, Lim JH#, Park HY#: Stable Clinical Course of Chronic Obstructive Pulmonary Disease Patients in the Era of Double Bronchodilator Therapy: A Single Referral Center Experience. Journal of Clinical Medicine 2020, 9(8):2547.

• 2019

  Ryu JS, Lim JH, Kim HJ, Kim MJ, Park MH, Kim JS: Survival prediction of tuberous sclerosis complex gene variant in patients with advanced non-small-cell lung cancer treated with platinum doublet. Bioscience reports 2019, 39(3):BSR20181426.

• 2019

  Lim JH, Ryu JS: Current perspective on the diagnosis of malignant pleural effusion. Journal of Thoracic Disease 2019, 3(2).

• 2019

  Ryu JS*, Lim JH*, Lee MK, Lee SJ, Kim HJ, Kim MJ, Park MH, Kim JS, Nam HS, Park N, Yong SJ: Feasibility of Bronchial Washing Fluid‐Based Approach to Early‐Stage Lung Cancer Diagnosis. The oncologist 2019:theoncologist. 2019-0147.

• 2019

  Yang B*, Choi H*, Lim JH, Park HY, Kang D, Cho J, Lee JS, Lee SW, Oh YM, Moon JY, Kim SH, Kim TH, Sohn JW, Yoon HJ, Lee H: The disease burden of bronchiectasis in comparison with chronic obstructive pulmonary disease: a national database study in Korea. ANNALS OF TRANSLATIONAL MEDICINE 2019, 7(23).

• 2018

  Lim JH, Ryu JS, Cho SY, Kim HJ, Jeon SH, Kim JS, Nam HS, Cho JH, Kwak SM, Lee HL: Small-cell lung cancer presenting as fatal pulmonary hemorrhage. Open Medicine 2018, 13(1):64-66.

• 2018

  Lim JH, Um SW: The risk factors for brain metastases in patients with non-small cell lung cancer. Annals of translational medicine 2018, 6(Suppl 1).

• 2018

  Lim JH, Ryu JS, Kim JH, Kim HJ, Lee D: Gender as an independent prognostic factor in small-cell lung cancer: Inha Lung Cancer Cohort study using propensity score matching. PloS one 2018, 13(12):e0208492.

• 2017

  Lee YS, Nam HS, Lim JH, Kim JS, Moon Y, Cho JH, Ryu JS, Kwak SM, Lee HL: Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients. BMC cancer 2017, 17(1):557.

• 2017

  Kim JS, Lim JH, Jeon SH, Choi JS, Kim YS, Nam HS: Topical mitomycin C application for the control of recurrent tracheal stenosis even after tracheal surgery. The International Journal of Tuberculosis and Lung Disease 2017, 21(12):1318-1320.

• 2016

  Ryu JS, Lim JH, Lee JM, Kim WC, Lee KH, Memon A, Lee SK, Yi BR, Kim HJ, Hwang SS: Minimal pleural effusion in small cell lung cancer: proportion, mechanisms, and prognostic effect. Radiology 2016, 278(2):593-600.

• 2015

  Lim JH, Lee JM, Choi SH, Nam HS, Cho JH, Ryu JS, Kwak SM: Alveolar Hemorrhage after Polyacrylamide Injection for Breast Augmentation. The Korean Journal of Medicine 2015, 88(4):438-441.

• 2015

  Lim JH, Nam HS, Kim HJ, Choi CH, Park IS, Cho JH, Ryu JS, Kwak SM, Lee HL: Migratory eosinophilic alveolitis caused by radiation therapy. Journal of thoracic disease 2015, 7(5):E117.

• 2014

  Kwon HY, Lim JH, Shin YW, Kim CW: A case of chronic cough caused by achalasia misconceived as gastroesophageal reflux disease. Allergy, asthma & immunology research 2014, 6(6):573-576.

• 2014

  Lee JM, Lim JH, Kim JS, Park JS, Memon A, Lee SK, Nam HS, Cho JH, Kwak SM, Lee HL, Kim HJ, Hong GJ, Ryu JS: Multiple hypercoagulability disorders at presentation of non-small-cell lung cancer. Tuberculosis and respiratory diseases 2014, 77(1):34-37.

• 2013

  Lim JH*, Jeon SH*, Lee JM, Kim L, Cho JH, Ryu JS, Kwak SM, Lee HL, Nam HS: Late-onset distant metastatic upper urinary tract urothelial carcinoma mimicking lung adenocarcinoma. Tuberculosis and respiratory diseases 2013, 75(1):32-35.

언론보도